Australia's largest stock trading and investment forum Australia's #1 stock forum

AZS

0.00%

$3.69 azure minerals limited

Takeover Time?, page-8

First 8 Last

Share
Profile

Follow
FastSell

513 Posts.

63

24/12/18

09:58

Post #: 36949724
Share

Originally posted by Mossberg: ↑

On 19 December, DB purchased 5,843,113 AZS shares for the modest sum of 11.5c p/s. According to the AR (p.59), Drake owns 5,843,113 shares. Clearly, Drake off-loaded its entire holding to DB (the only entity prepared to buy it), at a fire-sale price (25% discount)

This explains why DB dumped 125,000 shares on 13 December (i.e. so it could purchase Drake's holding without passing the 20% cap). Interestingly, Tony Rovira & Peter Ingram were busy buying shares the same day (160,000 & 170,000 respectively in this period)

With respect to Adesso' question about whether Directors purchased shares in response to the DB acquisition, and/or possibility of a T/O offer, prior to the sub notice being disclosed to market ... I hope not. That wouldn't be fair or ethical, imo. No-one should insinuate such things without supporting evidence.

Finally, Adesso' claim that 'all three directors have boosted their holdings' is misleading. The 3Y published 21 Dec shows Dr Martinick, and Mssrs Rovira & Ingram simply received their generous options packages awarded to them by grateful shareholders at the AGM.

In summary: What we see here is the capitulation of a long-term AZS corner-stone (Drake), coinciding with some opportunistic 'averaging-down' by Deutsche Balaton.

Expand

If memory serves me correctly, Drake bought in 2013, when the SP was ~$1 (post consolidation), so selling at $0.115 they took a bath. I imagine their position surmises that of all current LT share holders; deep in the red with this stock. It also suggests they have no confidence in Oposura paying off, in spite of management's box ticking.

AZS Price at posting: 15.0¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 17 more messages in this thread...

First 8 Last

Add AZS (ASX) to my watchlist

Takeover Time?, page-8

Top Stories

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News